← Back to Search

Other

LIPO-202 for Abdominal Bulge

Phase 2
Waitlist Available
Research Sponsored by Neothetics, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Central abdominal bulging that is at least "Slight Bulge, Not Flat"
Healthy male or non-pregnant female subjects
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will study the safety and effectiveness of LIPO-202 in non-obese patients with central abdominal bulging.

Who is the study for?
This trial is for healthy adults with a BMI under 30 who have central abdominal bulging. They must not be pregnant or breastfeeding, should maintain a stable diet and exercise routine, and haven't had any fat reduction treatments on their abdomen.Check my eligibility
What is being tested?
The study tests the safety of LIPO-202 through three 8-week treatment courses in non-obese patients with abdominal hernia. It also looks at how effective these treatments are in reducing belly bulge.See study design
What are the potential side effects?
While specific side effects aren't listed here, participants will be monitored for any adverse reactions to LIPO-202 during the repeated courses of treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a noticeable bulge in my abdomen.
Select...
I am a healthy male or a non-pregnant female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety: vital signs, physical exams, laboratory tests

Side effects data

From 2015 Phase 3 trial • 793 Patients • NCT02398188
27%
Injection Site Bruising
3%
Injection Site Haemorrhage
3%
Injection Site Pain
1%
Upper Respiratory Tract Infection
1%
Injection Site Erythema
100%
80%
60%
40%
20%
0%
Study treatment Arm
LIPO-202
Placebo

Trial Design

1Treatment groups
Experimental Treatment
Group I: LIPO-202Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LIPO-202
2015
Completed Phase 3
~1880

Find a Location

Who is running the clinical trial?

Neothetics, IncLead Sponsor
12 Previous Clinical Trials
2,962 Total Patients Enrolled
Maria FeldmanStudy DirectorNeothetics, Inc
4 Previous Clinical Trials
1,813 Total Patients Enrolled

Media Library

LIPO-202 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02397525 — Phase 2
Abdominal Hernia Research Study Groups: LIPO-202
Abdominal Hernia Clinical Trial 2023: LIPO-202 Highlights & Side Effects. Trial Name: NCT02397525 — Phase 2
LIPO-202 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02397525 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How widely-dispersed is the ongoing research in regards to participant locations within the US?

"The Dermatology Research Institute, LLC in Coral Gables, Florida, the Dermatology Clinical Research Center of San Antonio in Texas and AboutSkin Dermatology in Englewood Colorado are just a few of the sites that are participating in this trial. 8 other clinical locations have also joined forces with this medical study."

Answered by AI

Has LIPO-202 earned the endorsement of the FDA?

"Despite having no prior evidence of efficacy, the safety profile of LIPO-202 was scored a 2 on our company's system due to existing data suggesting it is safe for use."

Answered by AI

Is the enrolment process for this research still open?

"According to the information hosted on clinicaltrials.gov, this medical experiment is no longer recruiting candidates as its most recent update occurred in August 2015. However, there are presently 1 other trials actively searching for participants."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
65+
What site did they apply to?
Dermatology Clinical Research Center of San Antonio
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
An Open-Label Study to Evaluate Retreatment With LIPO-202
2015. "An Open-Label Study to Evaluate Retreatment With LIPO-202". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02397525.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top